Phase Holographic Imaging
Business Services · Sweden · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Scheelevägen 22, Lund, Skane, 223 63, Sw...Phone Number
+46 46386080Website
www.phiab.comRevenue
$5.9 MillionIndustry
About Phase Holographic Imaging
Phase Holographic Imaging Org Chart
Is Phase Holographic Imaging your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Phase Holographic Imaging had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Phase Holographic Imaging
Check if Phase Holographic Imaging has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Phase Holographic Imaging recently announced quarterly report
Funding: Get notified immidiatlly once Phase Holographic Imaging has new funding data
Check out if Phase Holographic Imaging is spiking on competitors!
Product Launch: Get notified when Phase Holographic Imaging launches new products
Phase Holographic Imaging, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Company Profile Activity
Activity Insights
Phase Holographic Imaging is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Phase Holographic Imaging is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Phase Holographic Imaging.
Phase Holographic Imaging Tech Stack
A closer look at the technologies used by Phase Holographic Imaging
Most Recent Scoops
Phase Holographic Imaging News & Media
The exercise period for warrants of series TO 4 commences today
Today is the first day for the exercise of Phase Holographic Imaging PHI AB's ("PHI" or "Company") warrants of series TO 4 ("TO 4") which were issued in connection with the preferential issue of units that the Company carried out during 2022. The period lasts until October 3, 2024. Holders of TO 4 have the right to subscribe for one (1) new share in PHI for each TO 4 at a price of SEK 4.63PHI enters the US capital market - shares now also traded on OTCQB
LUND, Sweden, Aug. 16, 2024 /PRNewswire/ -- Phase Holographic Imaging (PHI) is thrilled to announce its official approval for listing on the OTCQB Venture Market in the U.S., with trading commencing yesterday, Thursday, August 15th. This marks an important milestone in expanding our reach...PHI AB annual general meeting moved to 27 October 2023
The board of Phase Holographic Imaging (PHI) AB has decided to move the company’s annual general meeting from 12 October 2023 to 27 October 2023. For practical reasons, the board of PHI AB has decided to move the annual general meeting from 12 October 2023 to 27 October 2023 at 13:00, Hotel Scandic Star in Lund. A notice of the general meeting will be sent out at least four weeks in advance. The decision doesThe exercise period for warrants of series TO 3 begins today
Today is the first day of the exercise period for Phase Holographic Imaging PHI AB’s (“PHI” or the “Company”) warrants of series TO 3, which were issued in connection with the Company's rights issue of units that was announced on 22 February 2022. Holders of warrants of series TO 3 have, for each warrant, the right to subscribe for one (1) new share in PHI at a price of SEK 3.78 per share. The exercise
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Phase Holographic Imaging
Phase Holographic Imaging PHI specializes in non-invasive live cell analysis through their innovative HoloMonitor system, which allows for label-free kinetic studies and cell quality control directly within incubators. Their products cater to researchers in fields such as cancer research, stem cell studies, and drug discovery, providing real-time m... Read More